Self care programs and multiple sclerosis: Physical therapeutics treatment - literature review;Place de l'ETP dans la prise en charge des scléroses en plaques en MPR: prise en charge non pharmacologique - Revue de pertinence de la littérature

Annals of Physical and Rehabilitation Medicine

Volumn 54, Issue 2, 2011, Pages 109-128

  Demaille Wlodyka, S ^a,b   Donze, C ^a,b   Givron, P ^c   Gallien, P ^d  

^a Groupe Hospitalier de l'Institut Catholique Lillois   (France)

^b Centre Hospitalier Saint Philibert GHICL   (France)

^c UNIVERSITÉ CLERMONT AUVERGNE   (France)

^d Pôle médecine physique et de réadaptation Saint Hélier ^*  (France)

Author keywords

Counseling; Multiple sclerosis; Patient education; Self care; Self management

Indexed keywords

BEHAVIOR DISORDER; CAREGIVER; COCHRANE LIBRARY; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL (TOPIC); DYSPHAGIA; EDUCATION PROGRAM; FALLING; FATIGUE; HEALTH STATUS; HUMAN; LOCOMOTION; MEDICAL EDUCATION; MEDICAL STAFF; MEDLINE; MOOD DISORDER; MULTIPLE SCLEROSIS; PAIN; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF CARE; SEXUAL DYSFUNCTION; SHORT SURVEY; SPASTICITY; STANDARDIZATION; TECHNICAL AID; UROGENITAL TRACT DISEASE; VISUAL DISORDER; WHEELCHAIR;

HUMANS; MULTIPLE SCLEROSIS; PATIENT EDUCATION AS TOPIC; SELF CARE;

EID: 79953168717     PISSN: 18770657     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rehab.2011.01.003     Document Type: Short Survey

References (98)

1. Abraham S.S., Yun P.T. Laryngopharyngeal dysmotility in multiple sclerosis. Dysphagia 2002, 17(1):69-74.
2. Andersson P.B., Goodkin D.E. Current pharmacologic treatment of multiple sclerosis symptoms. West J Med 1996, 165(5):313-317.
3. Balcer L.J., Baier M.L., Kunkle A.M., Rudick R.A., Weinstock-Guttman B., Simonian N., et al. Self-reported visual dysfunction in multiple sclerosis: results from the 25-Item National Eye Institute Visual Function Questionnaire (VFQ-25). Mult Scler 2000, 6(6):382-385.
4. Barron C. Low vision rehabilitation of multiple sclerosis: a case report. J Am Optom Assoc 1993, 64(1):38-44.
5. Baum H.M., Rothschild B.B. Multiple sclerosis and mobility restriction. Arch Phys Med Rehabil 1983, 64(12):591-596.
6. Blake D.J., Bodine C. An overview of assistive technology for persons with multiple sclerosis. J Rehabil Res Dev 2002, 39(2):299-312.
7. Bombardier C.H., Cunniffe M., Wadhwani R., Gibbons L.E., Blake K.D., Kraft G.H. The efficacy of telephone counseling for health promotion in people with multiple sclerosis: a randomized controlled trial. Arch Phys Med Rehabil 2008, 89(10):1849-1856.
8. Boss T.M., Finlayson M. Responses to the acquisition and use of power mobility by individuals who have multiple sclerosis and their families. Am J Occup Ther 2006, 60(3):348-358.
9. Bramanti P., Sessa E., Rifici C., D'Aleo G., Floridia D., Di Bella P., et al. Enhanced spasticity in primary progressive MS patients treated with interferon beta-1b. Neurology 1998, 51(6):1720-1723.
10. Brittle N., Brown M., Mant J., McManus R., Riddoch J., Sackley C. Short-term effects on mobility, activities of daily living and health-related quality of life of a Conductive Education programme for adults with multiple sclerosis, Parkinson's disease and stroke. Clin Rehabil 2008, 22(4):329-337.
11. Calcagno P., Ruoppolo G., Grasso M.G., De Vincentiis M., Paolucci S. Dysphagia in multiple sclerosis - Prevalence and prognostic factors. Acta Neurol Scand 2002, 105(1):40-43.
12. Cattaneo D., De Nuzzo C., Fascia T., Macalli M., Pisoni I., Cardini R. Risks of falls in subjects with multiple sclerosis. Arch Phys Med Rehabil 2002, 83(6):864-867.
13. Chaudhuri A., Behan P.O. Treatment of multiple sclerosis: beyond the NICE guidelines. QJM 2005, 98(5):373-378.
14. Christopherson J.M., Moore K., Foley F.W., Warren K.G. A comparison of written materials vs. materials and counselling for women with sexual dysfunction and multiple sclerosis. J Clin Nurs 2006, 15(6):742-750.
15. Cole S.R., Beck R.W., Moke P.S., Gal R.L., Long D.T. The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Optic Neuritis Treatment Trial. Invest Ophthalmol Vis Sci 2000, 41(5):1017-1021.
16. Confavreux C., Vukusic S., Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 2003, 126(Pt 4):770-782.
17. Confavreux C., Vukusic S., Moreau T., Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med 2000, 343(20):1430-1438.
18. Creange A., Serre I., Levasseur M., Audry D., Nineb A., Boerio D., et al. Walking capacities in multiple sclerosis measured by global positioning system odometer. Mult Scler 2007, 13(2):220-223.
19. Dalgas U., Stenager E., Jakobsen J., Petersen T., Hansen H.J., Knudsen C., et al. Resistance training improves muscle strength and functional capacity in multiple sclerosis. Neurology 2009, 73(18):1478-1484.
20. de Seze M., Ruffion A., Denys P., Joseph P.A., Perrouin-Verbe B. The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult Scler 2007, 13(7):915-928.
21. Debouverie M., Pittion-Vouyovitch S., Louis S., Guillemin F. Validity of a French version of the fatigue impact scale in multiple sclerosis. Mult Scler 2007, 13(8):1026-1032.
22. Demers L., Monette M., Lapierre Y., Arnold D.L., Wolfson C. Reliability, validity, and applicability of the Quebec User Evaluation of Satisfaction with assistive Technology (QUEST 2.0) for adults with multiple sclerosis. Disabil Rehabil 2002, 24(1-3):21-30.
23. Ennis M., Thain J., Boggild M., Baker G.A., Young C.A. A randomized controlled trial of a health promotion education programme for people with multiple sclerosis. Clin Rehabil 2006, 20(9):783-792.
24. Finlayson M. Pilot study of an energy conservation education program delivered by telephone conference call to people with multiple sclerosis. NeuroRehabilitation 2005, 20(4):267-277.
25. Finlayson M., Cho C. A descriptive profile of caregivers of older adults with MS and the assistance they provide. Disabil Rehabil 2008, 30(24):1848-1857.
26. Finlayson M., Peterson E.W., Cho C. Pilot study of a fall risk management program for middle aged and older adults with MS. NeuroRehabilitation 2009, 25(2):107-115.
27. Finlayson M.L., Peterson E.W., Fujimoto K.A., Plow M.A. Rasch validation of the falls prevention strategies survey. Arch Phys Med Rehabil 2009, 90(12):2039-2046.
28. Fisk J.D., Pontefract A., Ritvo P.G., Archibald C.J., Murray T.J. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci 1994, 21(1):9-14.
29. Forbes A., While A., Mathes L., Griffiths P. Health problems and health-related quality of life in people with multiple sclerosis. Clin Rehabil 2006, 20(1):67-78.
30. Fowler C.J., Griffiths D., de Groat W.C. The neural control of micturition. Nat Rev Neurosci 2008, 9(6):453-466.
31. Fowler C.J., Panicker J.N., Drake M., Harris C., Harrison S.C., Kirby M., et al. A UK consensus on the management of the bladder in multiple sclerosis. J Neurol Neurosurg Psychiatry 2009, 80(5):470-477.
32. Frese A., Bethke F., Ludemann P., Stogbauer F. Enhanced spasticity in primary progressive MS patients treated with interferon beta-1b. Neurology 1999, 53(8):1892-1893.
33. Frohman E.M., Stüve O., Havrdova E., Corboy J., Achiron A., Zivadinov R., et al. Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations. Arch Neurol 2005, 62(10):1519-1530.
34. Gray E. The management of pain in multiple sclerosis: a care-study approach. Br J Nurs 2004, 13(17):1017-1020.
35. Heesen C., Segal J., Reich C., Hamalainen P., Broemel F., Niemann S., et al. Patient information on cognitive symptoms in multiple sclerosis - Acceptability in relation to disease duration. Acta Neurol Scand 2006, 114(4):268-272.
36. Holberg C., Finlayson M. factors influencing the use of energy conservation strategies by persons with multiple sclerosis. Am J Occup Ther 2007, 61(1):96-107.
37. Hughes R.B., Robinson-Whelen S., Taylor H.B., Hall J.W. Stress self-management: an intervention for women with physical disabilities. Womens Health Issues 2006, 16(6):389-399.
38. Jensen M.P., Barber J., Romano J.M., Molton I.R., Raichle K.A., Osborne T.L., et al. A comparison of self-hypnosis versus progressive muscle relaxation in patients with multiple sclerosis and chronic pain. Int J Clin Exp Hypn 2009, 57(2):198-221.
39. Johnson K.L., Bamer A.M., Yorkston K.M., Amtmann D. Use of cognitive aids and other assistive technology by individuals with multiple sclerosis. Disabil Rehabil Assist Technol 2009, 4(1):1-8.
40. Kasper J., Kopke S., Muhlhauser I., Heesen C. Evidence-based patient information about treatment of multiple sclerosis: a phase one study on comprehension and emotional responses. Patient Educ Couns 2006, 62(1):56-63.
41. Kinnman J., Andersson T., Andersson G. Effect of cooling suit treatment in patients with multiple sclerosis evaluated by evoked potentials. Scand J Rehabil Med 2000, 32(1):16-19.
42. Koopman W.J., Benbow C.L., Vandervoort M. Top 10 needs of people with multiple sclerosis and their significant others. J Neurosci Nurs 2006, 38(5):369-373.
43. Köpke S., Kasper J., Mühlhauser I., Nübling M., Heesen C. Patient education program to enhance decision autonomy in multiple sclerosis relapse management: a randomized-controlled trial. Mult Scler 2009, 15(1):96-104.
44. Krupp L.B., La Rocca N.G., Muir-Nash J., Steinberg A.D. The Fatigue Severity Scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989, 46:1121-1123.
45. Lamb A.L., Finlayson M., Mathiowetz V., Chen H.Y. The outcomes of using self-study modules in energy conservation education for people with multiple sclerosis. Clin Rehabil 2005, 19(5):475-481.
46. Landtblom A.M., Lang C., Flensner G. The study circle as a tool in multiple sclerosis patient education in Sweden. Patient Prefer Adherence 2008, 2:225-232.
47. Leary S.M., Thompson A.J. Interferon beta-1a in primary progressive multiple sclerosis. J Neurol Sci 2003, 206(2):215-216.
48. Leary S.M., Thompson A.J. The effect of interferon beta-1a on spasticity in primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 2004, 75(3):508-509.
49. Leboeuf L., Mendez L.E., Gousse A.E. Small bowel obstruction associated with tension-free vaginal tape. Urology 2004, 63(6):1182-1184.
50. Lebrun C. Therapeutic indications in spasticity symptoms of multiple sclerosis. Rev Neurol (Paris) 2001, 157(8-9 Pt 2):1045-1050.
51. Liepold A., Mathiowetz V. Reliability and validity of the Self-Efficacy for Performing Energy Conservation Strategies Assessment for persons with multiple sclerosis. Occup Ther Int 2005, 12(4):234-249.
52. Mangione C.M., Lee P.P., Pitts J., Gutierrez P., Berry S., Hays R.D. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators. Arch Ophthalmol 1998, 116(11):1496-1504.
53. Marrie R.A., Cutter G., Tyry T., Hadjimichael O., Vollmer T. Validation of the NARCOMS Registry: pain assessment. Mult Scler 2005, 11(3):338-342.
54. Mathiowetz V., Matuska K.M., Murphy M.E. Efficacy of an energy conservation course for persons with multiple sclerosis. Arch Phys Med Rehabil 2001, 82(4):449-456.
55. Mathiowetz V.G., Matuska K.M., Finlayson M.L., Luo P., Chen H.Y. One-year follow-up to a randomized controlled trial of an energy conservation course for persons with multiple sclerosis. Int J Rehabil Res 2007, 30(4):305-313.
56. Matuska K., Mathiowetz V., Finlayson M. Use and perceived effectiveness of energy conservation strategies for managing multiple sclerosis fatigue. Am J Occup Ther 2007, 61(1):62-69.
57. McDonald W.I., Barnes D. The ocular manifestations of multiple sclerosis. 1. Abnormalities of the afferent visual system. J Neurol Neurosurg Psychiatry 1992, 55(9):747-752.
58. Motl R.W., Mc Auley E., Snook E.M. Physical activity and multiple sclerosis: a meta-analysis. Mult Scler 2005, 11:459-463.
59. Moore A.C., MacLeod A.K., Barnes D., Langdon D.W. Future-directed thinking and depression in relapsing-remitting multiple sclerosis. Br J Health Psychol 2006, 11(Pt 4):663-675.
60. Mowry E.M., Loguidice M.J., Daniels A.B., Jacobs D.A., Markowitz C.E., Galetta S.L., et al. Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity. J Neurol Neurosurg Psychiatry 2009, 80(7):767-772.
61. Norton C., Cody J.D., Hosker G. Biofeedback and/or sphincter exercises for the treatment of faecal incontinence in adults. Cochrane Database Syst Rev 2006, 3:CD002111.
62. O'Hara L., Cadbury H., De S.L., Ide L. Evaluation of the effectiveness of professionally guided self-care for people with multiple sclerosis living in the community: a randomized controlled trial. Clin Rehabil 2002, 16(2):119-128.
63. Patti F., Ciancio M.R., Reggio E., Lopes R., Palermo F., Cacopardo M., et al. The impact of outpatient rehabilitation on quality of life in multiple sclerosis. J Neurol 2002, 249(8):1027-1033.
64. Perks B.A., Mackintosh R., Stewart C.P., Bardsley G.I. A survey of marginal wheelchair users. J Rehabil Res Dev 1994, 31(4):297-302.
65. Petajean J.H., Gappmaier E., White A.T., Spencer M.K., Plino L., Hicks R.W. Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol 1996, 39:432-441.
66. Petrilli S., Durufle A., Nicolas B., Robineau S., Kerdoncuff V., Le Tallec H., et al. Influence of temperature changes on clinical symptoms in multiple sclerosis: an epidemiologic study. Ann Readapt Med Phys 2004, 47(5):204-208.
67. Phillips B., Zhao H. Predictors of assistive technology abandonment. Assist Technol 1993, 5(1):36-45.
68. Plow M.A., Mathiowetz V., Lowe D.A. Comparing individualized rehabilitation to a group wellness intervention for persons with multiple sclerosis. Am J Health Promot 2009, 24(1):23-26.
69. Preziosi G., Emmanuel A. Neurogenic bowel dysfunction: pathophysiology, clinical manifestations and treatment. Expert Rev Gastroenterol Hepatol 2009, 3(4):417-423.
70. Prunty M., Sharpe L., Butow P., Fulcher G. The motherhood choice: themes arising in the decision-making process for women with multiple sclerosis. Mult Scler 2008, 14(5):701-704.
71. Rannou F., Coudeyre E., Ribinik P., Mace Y., Poiraudeau S., Revel M. Establishing recommendations for physical medicine and rehabilitation: the SOFMER methodology. Ann Readapt Med Phys 2007, 50(2):100-110.
72. Rigby S.A., Thornton E.W., Young C.A. A randomized group intervention trial to enhance mood and self-efficacy in people with multiple sclerosis. Br J Health Psychol 2008, 13(Pt 4):619-631.
73. Rizzo M.A., Hadjimichael O.C., Preiningerova J., Vollmer T.L. Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult Scler 2004, 10(5):589-595.
74. Romberg A., Virtanen A., Aunola S., Karppi S.L., Karanko H., Ruutiainen J. Exercise capacity, disability and leisure physical activity of subjects with multiple sclerosis. Mult Scler 2004, 10(2):212-218.
75. Sauter C., Zebenholzer K., Hisakawa J., Zeitlhofer J., Vass K. A longitudinal study on effects of a six-week course for energy conservation for multiple sclerosis patients. Mult Scler 2008, 14(4):500-505.
76. Shevil E., Finlayson M. Process evaluation of a self-management cognitive program for persons with multiple sclerosis. Patient Educ Couns 2009, 76(1):77-83.
77. Shevil E., Finlayson M. Pilot study of a cognitive intervention program for persons with multiple sclerosis. Health Educ Res 2010, 25(1):41-53.
78. Simmons R.D., Ponsonby A.L., van der Mei I.A., Sheridan P. What affects your MS? Responses to an anonymous. Internet-based epidemiological survey. Mult Scler 2004, 10(2):202-211.
79. Smestad C., Sandvik L., Celius E.G. Excess mortality and cause of death in a cohort of Norwegian multiple sclerosis patients. Mult Scler 2009, 15(11):1263-1270.
80. Stelmack J.A., Stelmack T.R., Massof R.W. Measuring low-vision rehabilitation outcomes with the NEI VFQ-25. Invest Ophthalmol Vis Sci 2002, 43(9):2859-2868.
81. Stuifbergen A.K., Rogers S. The experience of fatigue and strategies of self-care among persons with multiple sclerosis. Appl Nurs Res 1997, 10(1):2-10.
82. Sutherland G., Andersen M.B., Morris T. Relaxation and health-related quality of life in multiple sclerosis: the example of autogenic training. J Behav Med 2005, 28(3):249-256.
83. Terre-Boliart R., Orient-Lopez F., Guevara-Espinosa D., Ramon-Rona S., Bernabeu-Guitart M., Clave-Civit P. Oropharyngeal dysphagia in patients with multiple sclerosis. Rev Neurol 2004, 39(8):707-710.
84. Thomas F.J., Wiles C.M. Dysphagia and nutritional status in multiple sclerosis. J Neurol 1999, 246(8):677-682.
85. Thompson A.J. Neurorehabilitation in multiple sclerosis: foundations, facts and fiction. Curr Opin Neurol 2005, 18(3):267-271.
86. Vahter L., Zopp I., Kreegipuu M., Kool P., Talvik T., Gross-Paju K. Clean intermittent self-catheterization in persons with multiple sclerosis: the influence of cognitive dysfunction. Mult Scler 2009, 15(3):379-384.
87. van Diemen H.A., van Dongen M.M., Dammers J.W., Polman C.H. Increased visual impairment after exercise (Uhthoff's phenomenon) in multiple sclerosis: therapeutic possibilities. Eur Neurol 1992, 32(4):231-234.
88. Vanage S.M., Gilbertson K.K., Mathiowetz V. Effects of an energy conservation course on fatigue impact for persons with progressive multiple sclerosis. Am J Occup Ther 2003, 57(3):315-323.
89. Warke K., Al-Smadi J., Baxter D., Walsh D.M., Lowe-Strong A.S. Efficacy of Transcutaneous Electrical Nerve Stimulation (TENS) for chronic low-back pain in a multiple sclerosis population: a randomized, placebo-controlled clinical trial. Clin J Pain 2006, 22(9):812-819.
90. Weinshenker B.G. Databases in MS research: pitfalls and promises. Mult Scler 1999, 5(4):206-211.
91. Wheeler G., Krausher K., Cumming C., Jung V., Steadward R., Cumming D. Personal styles and ways of coping in individuals who use wheelchairs. Spinal Cord 1996, 34(6):351-357.
92. Wiesel P.H., Norton C., Brazzelli M. Management of faecal incontinence and constipation in adults with central neurological diseases. Cochrane Database Syst Rev 2001, 4:CD002115.
93. Wiesel P.H., Norton C., Roy A.J., Storrie J.B., Bowers J., Kamm M.A. Gut focused behavioural treatment (biofeedback) for constipation and faecal incontinence in multiple sclerosis. J Neurol Neurosurg Psychiatry 2000, 69(2):240-243.
94. Wolffsohn J.S., Cochrane A.L. Design of the low vision quality-of-life questionnaire (LVQOL) and measuring the outcome of low-vision rehabilitation. Am J Ophthalmol 2000, 130(6):793-802.
95. Zorzon M., Zivadinov R., Bosco A., Bragadin L.M., Moretti R., Bonfigli L., et al. Sexual dysfunction in multiple sclerosis: a case-control study. I. Frequency and comparison of groups. Mult Scler 1999, 5(6):418-427.
96. Afssaps. Agence française de sécurité sanitaire des produits de santé; 2009.
97. HAS. Haute Autorité en santé, recommandations, éducation thérapeutique du patient - Définitions, finalités et organisation; 2007.
98. The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol 1991, 109(12):1673-1678. Optic Neuritis Study Group.